Highlights the clinical need to assess coronary microcirculation in STEMI patients post-PCI to identify those at high risk for subsequent heart failure.
T he primary management goal in patients with ST- elevation myocardial infarction (STEMI) is to restore blood flow to the myocardium subtended by the occluded epicardial artery using pharmacologic and mechanical means. However, despite contemporary approaches with primary percutaneous coronary intervention (PCI) and subsequent medical therapy, the morbidity and mortality of patients with STEMI have not changed significantly over recent years. 1 Moreover, 10% to 20% of patients who survive to 5 years after STEMI will develop heart failure. 2 There is therefore a need to develop and validate methods that can identify patients early who are at risk of subsequent adverse events that might be reduced by targeted adjunctive therapies.
No takes yet. Share an insight, caveat, or question.
Yong et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: